vs
bioAffinity Technologies, Inc.（BIAF）与NATIONAL RESEARCH CORP（NRC）财务数据对比。点击上方公司名可切换其他公司
NATIONAL RESEARCH CORP的季度营收约是bioAffinity Technologies, Inc.的22.1倍（$35.2M vs $1.6M）。NATIONAL RESEARCH CORP净利率更高（5.1% vs -197.0%，领先202.1%）。NATIONAL RESEARCH CORP同比增速更快（-4.6% vs -27.8%）。NATIONAL RESEARCH CORP自由现金流更多（$6.1M vs $-2.6M）。过去两年NATIONAL RESEARCH CORP的营收复合增速更高（-0.2% vs -18.6%）
bioAffinity Technologies是一家处于临床阶段的生物技术企业，专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品，面向全球医疗市场，致力于提供高准确率的便捷诊断方案，改善患者诊疗体验与预后效果。
NRC Health（原国家研究公司）是一家美国医疗健康企业，1981年成立，总部位于内布拉斯加州林肯市。公司主要在美加两国提供医疗健康相关产品及订阅式解决方案，深耕区域医疗健康服务领域。
BIAF vs NRC — 直观对比
营收规模更大
NRC
是对方的22.1倍
$1.6M
营收增速更快
NRC
高出23.2%
-27.8%
净利率更高
NRC
高出202.1%
-197.0%
自由现金流更多
NRC
多$8.6M
$-2.6M
两年增速更快
NRC
近两年复合增速
-18.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $35.2M |
| 净利润 | $-3.1M | $1.8M |
| 毛利率 | — | — |
| 营业利润率 | -196.9% | 13.3% |
| 净利率 | -197.0% | 5.1% |
| 营收同比 | -27.8% | -4.6% |
| 净利润同比 | -5.7% | -72.6% |
| 每股收益（稀释后） | $-3.59 | $49.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIAFNRC
| Q4 25 | $1.6M | $35.2M | ||
| Q3 25 | $1.4M | $34.6M | ||
| Q2 25 | $1.3M | $34.0M | ||
| Q1 25 | $1.9M | $33.6M | ||
| Q4 24 | $2.2M | $36.9M | ||
| Q3 24 | $2.4M | $35.8M | ||
| Q2 24 | $2.4M | $35.0M | ||
| Q1 24 | $2.4M | $35.3M |
净利润BIAFNRC
| Q4 25 | $-3.1M | $1.8M | ||
| Q3 25 | $-5.1M | $4.1M | ||
| Q2 25 | $-4.1M | $-106.0K | ||
| Q1 25 | $-2.7M | $5.8M | ||
| Q4 24 | $-3.0M | $6.6M | ||
| Q3 24 | $-2.0M | $5.7M | ||
| Q2 24 | $-2.1M | $6.2M | ||
| Q1 24 | $-2.0M | $6.4M |
营业利润率BIAFNRC
| Q4 25 | -196.9% | 13.3% | ||
| Q3 25 | -158.6% | 22.4% | ||
| Q2 25 | -198.2% | 4.7% | ||
| Q1 25 | -141.7% | 25.6% | ||
| Q4 24 | -133.5% | 26.0% | ||
| Q3 24 | -84.0% | 22.3% | ||
| Q2 24 | -87.1% | 25.3% | ||
| Q1 24 | -80.8% | 24.8% |
净利率BIAFNRC
| Q4 25 | -197.0% | 5.1% | ||
| Q3 25 | -349.3% | 11.9% | ||
| Q2 25 | -319.9% | -0.3% | ||
| Q1 25 | -143.5% | 17.2% | ||
| Q4 24 | -134.4% | 17.8% | ||
| Q3 24 | -85.1% | 15.9% | ||
| Q2 24 | -88.0% | 17.6% | ||
| Q1 24 | -81.5% | 18.0% |
每股收益（稀释后）BIAFNRC
| Q4 25 | $-3.59 | $49.58 | ||
| Q3 25 | $-4.74 | $0.18 | ||
| Q2 25 | $-0.17 | $-0.01 | ||
| Q1 25 | $-0.16 | $0.25 | ||
| Q4 24 | $-17.27 | $0.27 | ||
| Q3 24 | $-4.84 | $0.24 | ||
| Q2 24 | $-0.19 | $0.26 | ||
| Q1 24 | $-0.20 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3M | $14.0M |
| 总资产 | $11.0M | $134.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIAFNRC
| Q4 25 | $6.4M | $4.1M | ||
| Q3 25 | $7.7M | $2.2M | ||
| Q2 25 | $802.8K | $5.3M | ||
| Q1 25 | $444.7K | $2.5M | ||
| Q4 24 | $1.1M | $4.2M | ||
| Q3 24 | $756.6K | $3.5M | ||
| Q2 24 | $801.3K | $485.0K | ||
| Q1 24 | $2.5M | $1.7M |
总债务BIAFNRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
股东权益BIAFNRC
| Q4 25 | $7.3M | $14.0M | ||
| Q3 25 | $8.9M | $14.3M | ||
| Q2 25 | $-2.1M | $21.3M | ||
| Q1 25 | $1.4M | $29.7M | ||
| Q4 24 | $2.6M | $31.3M | ||
| Q3 24 | $3.1M | $34.6M | ||
| Q2 24 | $3.4M | $40.2M | ||
| Q1 24 | $5.3M | $36.9M |
总资产BIAFNRC
| Q4 25 | $11.0M | $134.9M | ||
| Q3 25 | $11.5M | $135.7M | ||
| Q2 25 | $4.8M | $141.4M | ||
| Q1 25 | $5.5M | $135.2M | ||
| Q4 24 | $6.5M | $132.5M | ||
| Q3 24 | $6.6M | $131.8M | ||
| Q2 24 | $6.7M | $119.1M | ||
| Q1 24 | $8.0M | $120.9M |
负债/权益比BIAFNRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | $6.1M |
| 自由现金流率自由现金流/营收 | -160.7% | 17.2% |
| 资本支出强度资本支出/营收 | 0.0% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 3.99× |
| 过去12个月自由现金流最近4个季度 | $-9.4M | $15.7M |
8季度趋势，按日历期对齐
经营现金流BIAFNRC
| Q4 25 | $-2.6M | $7.2M | ||
| Q3 25 | $-2.5M | $13.8M | ||
| Q2 25 | $-2.6M | $-1.1M | ||
| Q1 25 | $-1.6M | $6.6M | ||
| Q4 24 | $-1.7M | $6.4M | ||
| Q3 24 | $-1.7M | $9.4M | ||
| Q2 24 | $-1.5M | $6.8M | ||
| Q1 24 | $-2.3M | $12.0M |
自由现金流BIAFNRC
| Q4 25 | $-2.6M | $6.1M | ||
| Q3 25 | $-2.5M | $10.2M | ||
| Q2 25 | $-2.7M | $-4.1M | ||
| Q1 25 | $-1.7M | $3.7M | ||
| Q4 24 | $-1.7M | $1.9M | ||
| Q3 24 | $-1.7M | $7.8M | ||
| Q2 24 | $-1.6M | $1.5M | ||
| Q1 24 | $-2.4M | $7.9M |
自由现金流率BIAFNRC
| Q4 25 | -160.7% | 17.2% | ||
| Q3 25 | -171.8% | 29.4% | ||
| Q2 25 | -209.6% | -12.2% | ||
| Q1 25 | -91.3% | 10.9% | ||
| Q4 24 | -76.0% | 5.2% | ||
| Q3 24 | -73.1% | 21.8% | ||
| Q2 24 | -65.1% | 4.3% | ||
| Q1 24 | -99.2% | 22.4% |
资本支出强度BIAFNRC
| Q4 25 | 0.0% | 3.2% | ||
| Q3 25 | 0.3% | 10.4% | ||
| Q2 25 | 1.1% | 8.8% | ||
| Q1 25 | 2.7% | 8.9% | ||
| Q4 24 | 0.0% | 12.0% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 1.2% | 15.0% | ||
| Q1 24 | 1.7% | 11.7% |
现金转化率BIAFNRC
| Q4 25 | — | 3.99× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
